Klor-Con



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Blood Potassium Decreased 24.0%
Mineral Supplementation 14.0%
Product Used For Unknown Indication 10.0%
Diuretic Therapy 6.0%
Arthritis 4.0%
Blood Cholesterol Increased 4.0%
Cardiac Disorder 4.0%
Depression 4.0%
Hypertension 4.0%
Hypokalaemia 4.0%
Urinary Incontinence 4.0%
Blood Potassium 2.0%
Blood Pressure Increased 2.0%
Colitis 2.0%
Diabetes Mellitus 2.0%
Drug Use For Unknown Indication 2.0%
Electrolyte Substitution Therapy 2.0%
Familial Periodic Paralysis 2.0%
Fibromyalgia 2.0%
Muscle Spasms 2.0%
Fatigue 10.3%
Medication Error 10.3%
Medication Residue Present 10.3%
Diarrhoea 6.9%
Drug Interaction 6.9%
Product Formulation Issue 6.9%
Blood Magnesium Decreased 3.4%
Colitis 3.4%
Convulsion 3.4%
Dizziness 3.4%
Drug Ineffective 3.4%
Flatulence 3.4%
Malaise 3.4%
Medication Residue 3.4%
Melaena 3.4%
Muscle Spasms 3.4%
Nausea 3.4%
Overdose 3.4%
Pancreatitis 3.4%
Product Physical Issue 3.4%
Secondary
Product Used For Unknown Indication 29.2%
Drug Use For Unknown Indication 10.3%
Blood Potassium Decreased 6.1%
Blood Pressure 6.1%
B-cell Lymphoma 5.5%
Prostate Cancer 4.6%
Foetal Exposure During Pregnancy 4.3%
Depression 4.0%
Arthritis 3.3%
Blood Cholesterol Increased 3.0%
Diabetes Mellitus 3.0%
Fibromyalgia 3.0%
Hypertension 2.7%
Pain 2.7%
Mineral Supplementation 2.4%
Diffuse Large B-cell Lymphoma 2.1%
Pulmonary Arterial Hypertension 2.1%
Gout 1.8%
Ill-defined Disorder 1.8%
Sleep Disorder 1.8%
Renal Failure Acute 11.5%
Urticaria 9.6%
Blood Potassium Decreased 5.8%
Dizziness 5.8%
Drug Interaction 5.8%
Hypertension 5.8%
Medication Residue Present 5.8%
Cerebrovascular Accident 3.8%
Diabetes Mellitus 3.8%
Gastric Ulcer Haemorrhage 3.8%
Insomnia 3.8%
Joint Swelling 3.8%
Medication Residue 3.8%
Myalgia 3.8%
Nausea 3.8%
Surgery 3.8%
Swelling 3.8%
Urine Arsenic Increased 3.8%
Vision Blurred 3.8%
Vomiting 3.8%
Concomitant
Product Used For Unknown Indication 32.7%
Drug Use For Unknown Indication 15.5%
Hypertension 9.8%
Pain 4.7%
Blood Cholesterol Increased 3.0%
Diabetes Mellitus 3.0%
Depression 3.0%
Atrial Fibrillation 3.0%
Cardiac Disorder 2.7%
Rheumatoid Arthritis 2.4%
Osteoporosis 2.3%
Multiple Myeloma 2.2%
Type 2 Diabetes Mellitus 2.2%
Anxiety 2.2%
Gastrooesophageal Reflux Disease 2.1%
Pulmonary Arterial Hypertension 2.0%
Asthma 1.9%
Prophylaxis 1.8%
Chronic Obstructive Pulmonary Disease 1.7%
Arthritis 1.7%
Weight Decreased 12.3%
Vomiting 12.0%
Weight Increased 10.9%
Death 8.3%
Pneumonia 5.1%
Urinary Tract Infection 5.0%
Drug Ineffective 4.5%
Dyspnoea 4.5%
Oedema Peripheral 4.0%
Myocardial Infarction 3.7%
Nausea 3.6%
Rash 3.4%
Pain 3.3%
Tremor 3.1%
Renal Failure Acute 2.9%
Syncope 2.9%
Vision Blurred 2.7%
Pain In Extremity 2.6%
Renal Failure 2.6%
Wheezing 2.5%
Interacting
Blood Pressure Abnormal 26.7%
Mineral Supplementation 16.7%
Blood Cholesterol Increased 13.3%
Diabetes Mellitus 13.3%
Product Used For Unknown Indication 13.3%
Atrial Fibrillation 3.3%
Blood Potassium Decreased 3.3%
Hypertension 3.3%
Hypertonic Bladder 3.3%
Urinary Incontinence 3.3%
Drug Interaction 42.9%
Drug Ineffective 28.6%
Medication Residue 14.3%
Nausea 14.3%